Literature DB >> 14715819

Orbital radiotherapy for Graves' ophthalmopathy.

Luigi Bartalena, Claudio Marcocci, Aldo Pinchera.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14715819     DOI： 10.1210/jc.2003-031769

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

Review 1.  An update on medical management of Graves' ophthalmopathy.

Authors:  L Bartalena; C Marcocci; M L Tanda; E Piantanida; A Lai; M Marinò; A Pinchera
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

2.  Quality of life in patients with Graves ophthalmopathy.

Authors:  R Patrick Yeatts
Journal:  Trans Am Ophthalmol Soc       Date:  2005

3.  Teprotumumab (Tepezza) for Thyroid Eye Disease.

Authors:  Steven M Couch
Journal:  Mo Med       Date:  2022 Jan-Feb

Review 4.  Thyroid associated orbitopathy.

Authors:  Rajat Maheshwari; Ezekiel Weis
Journal:  Indian J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 1.848

5.  Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial.

Authors:  Rathie Rajendram; Richard W J Lee; Mike J Potts; Geoff E Rose; Rajni Jain; Jane M Olver; Fion Bremner; Steven Hurel; Anne Cook; Rao Gattamaneni; Marjorie Tomlinson; Nicholas Plowman; Catey Bunce; Sandra P Hollinghurst; Laura Kingston; Sue Jackson; Andrew D Dick; Nichola Rumsey; Olivia C Morris; Colin M Dayan; Jimmy M Uddin
Journal:  Trials       Date:  2008-01-31       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.